Analytical Validation of a Candidate Biomarker for Neurological Disease (U44 - Clinical Trial Optional)
ID: PAR-18-549 • Type: Posted
Overview
Category of Funding
Health
Funding Instruments
Cooperative Agreement
Grant Program (CFDA)
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 12/22/17 the National Institutes of Health posted grant opportunity PAR-18-549 for Analytical Validation of a Candidate Biomarker for Neurological Disease (U44 - Clinical Trial Optional).
The grant will be issued under grant program 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders.
Timing
Posted Date
Dec. 22, 2017, 12:00 a.m. EST
Closing Date
Sept. 7, 2020, 12:00 a.m. EDT Past Due
Version
1
Archive Date
Oct. 13, 2020
Eligibility
Eligible Applicants
Small businesses
Additional Info
Other Eligible Applicants include the following: Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. see funding announcement for eligibility
Contacts
Contact
National Institutes of Health
Contact Email
Email Description
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Contact Phone
(301) 496-3405
Additional Information Site